Clinical Trial Update: A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy [Phase 2]

View source ↗

Summary

A Phase 2 study of belimumab in idiopathic membranous nephropathy has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Glomerulonephritis, Membranous | Phase 2 | Status: COMPLETED | Results posted: 2015-06-01